Biochemistry
Fourth Edition
Donald Voet Judith G. Voet
Charlotte W. Pratt
Chapter 12
Enzyme Kinetics, Inhibition, and Control
Copyright 2013 by John Wiley & Sons, Inc. All rights reserved.
Atorvastatin (Lipitor)
Atorvastatin
PDBid 1HWK
Chapter 12
Reaction Kinetics
Key Concepts 12.1
Simple rate equations describe the progress of first-order
and second-order reactions.
The MichaelisMenten equation relates the initial velocity
of a reaction to the maximal reaction velocity and the
Michaelis constant for a particular enzyme and substrate.
An enzymes overall catalytic efficiency is expressed as
kcat/KM.
A LineweaverBurk plot can be used to present kinetic
data and to calculate values for KM and Vmax.
Bisubstrate reactions can occur by an Ordered or Random
sequential mechanism or by a Ping Pong mechanism.
Kinetics
1.
Kinetics: the study of the rates at which chemical reactions occur; the rate of
a reaction and how this rate changes in response to different conditions is
intimately related to the path followed by the reaction and is therefore indicative
of its reaction mechanism
2. Enzyme Kinetics
a. Through kinetic studies the binding affinities of substrates and inhibitors to
an enzyme can be determined and the maximum catalytic rate of an
enzyme can be established.
b. By observing how the rate of an enzymatic reaction varies with the
reactions conditions and combining this information with that obtained from
chemical and structural studies of the enzyme, the enzymes catalytic
mechanism may be elucidated.
c. Most enzymes function as members of metabolic pathways; the study of
the kinetics of an enzymatic reaction leads to an understanding of that
enzymes role in an overall metabolic process.
d. Under proper conditions, the rate of an enzymatically catalyzed reaction is
proportional to the amount of the enzyme present and therefore most
enzyme assays are based on kinetic studies of the enzyme; Measurements
of enzymatically catalyzed reaction rates are therefore among the most
4
commonly employed procedures in biochemical and clinical analyses
Rates of Reaction
1. Simpler molecular processes by which a reaction may occur
A I1 I2 P
where I1 and I2 symbolize intermediates and thus its mechanistic description
2. Rates of Reactions
a. The order of a reaction can be experimentally determined by
measuring [A] or [P] as a function of time:
b.
v = - d[A] = d[P]
dt
dt
where v is the instantaneous rate (velocity) of the reaction
c.
Rate Equation
1. Rate of a process is proportional to the frequency with which the
reacting molecules simultaneously come together to the products of
the concentrations of the reactants
2.
9
Box 12-1a
Enzyme Kinetics
Nomenclature
Kinetic Mechanism --- A detailed
description of a series of elementary
reactions that describe an enzyme-catalyzed
reaction.
Chemical Mechanism --- A detailed
description of the chemistry of each step
including structures of transition states,
resonance etc.
11
Nomenclature
Enzyme --- E
Reactants --- A, B, C..
Products --- P, Q, R..
Inhibitors --- I, J, K.
Non-covalent complex --- ES
Commonly abbreviate [E] by omitting the brackets (eg.
E assumes molar concentration)
Rate constants --- k1, k-1, k2, etc.
12
13
MichaelisMenten Model
1. Enzyme-substrate complex: when the substrate concentration
becomes high enough to entirely convert the enzyme to the ES
form (Michaelis complex), the second step of the reaction
becomes rate limiting and the overall reaction rate becomes
insensitive to further increases in substrate concentration
2. Assumption of equilibrium: k-1 >> k2 so that the first step of the
reaction achieves equilibrium
3. Assumption of Steady State: [ES] remains approximately
constant until the substrate is nearly exhausted
14
Michaelis-Menten Equation
4.
5.
6.
16
Michaelis-Menten Kinetics
7.
Quantity is also known as turnover number because it is the number of reaction processes
that each active site catalyzes per unit time
8.
19
Lineweaver-Burke Equation
10. Lineweaver-Burk equation for determining the values of Vmax
20
Page 373
Double-Reciprocal
(Lineweaver-Burk) Plot
Bisubstrate Reactions
1.
24
Figure 12-5
Bisubstrate Reactions
Terminology by W. W. Cleland for representing enzymatic
reactions:
1.Substrates are designated by letters A, B, C, and D in the order
that they add to the enzyme
2.Stable enzyme forms are designated E, F, and G with E being the
free enzyme. A stable enzyme form is defined as one that by itself is
incapable of converting to another stable enzyme form
25
Page 375
Bisubstrate Reactions
3. Products are designated P, Q, R, and S in the order that
they leave the enzyme
4. The number of reactants and products in a given reaction
are specified, in order, by the terms Uni (one), Bi (two), Ter
(three), and Quad (four)
26
Bisubstrate Reactions
Bisubstrate Reactions
Sequential reactions
1. Reactions in which all substrates must combine with the
enzyme before a reaction can occur and products be released
2. Ordered mechanism: a compulsory order of substrate
addition to the enzyme
3. Random mechanism: no preference for the order of substrate
addition
4. Characteristic feature of sequential Bi Bi reactions is that the
lines intersect to the left of the 1/v0 axis
29
Page 376
Bisubstrate Reactions
Rate Equations
1.Steady state kinetic measurements can be used to distinguish
among the foregoing bisubstrate mechanisms
2.Vmax is the maximal velocity of the enzyme obtained when both
A and B are present at saturating concentrations; KAM and KBM
are the respective concentrations of A and B necessary to
achieve Vmax in the presence of a saturating concentration of
the other; KAS and KBS are the respective dissociation constants
of A and B from the enzyme E
Page 376
32
Bisubstrate Reactions
Ping Pong Reactions
1.Mechanisms in which one or more products are released before all
substrates have been added
2.Also known as double-displacement reactions where substrates A and B
do not encounter one another on the surface of the enzyme
3.Parallel lines are diagnostic for Ping Pong mechanisms
Isotope Exchange
1.Sequential and Ping Pong bisubstrate mechanisms may be
differentiated using isotope exchange studies
2.Enzymes sucrose phosphorylase and maltose phosphorylase provide
two clearcut examples of enzymatically catalyzed isotopic reactions
33
Chapter 12
Reaction Kinetics
Checkpoint 12.1
Write the rate equations for a first-order and a secondorder reaction.
If you know a reactions half-life, can you determine its rate
constant? What other information do you need?
What are the differences between instantaneous velocity,
initial velocity, and maximal velocity for an enzymatic
reaction?
Derive the MichaelisMenten equation.
Chapter 12
Reaction Kinetics
Checkpoint 12.1
What do the values of KM and kcat/KM reveal about an
enzyme?
Why cant an enzyme have a kcat/KM value greater than 109
M1 s1?
Write the LineweaverBurk (double reciprocal) equation
and describe the features of a LineweaverBurk plot.
Why cant enzyme kinetics prove that a particular enzyme
mechanism is correct?
Use Cleland notation to describe Ordered and Random
sequential reactions and a Ping Pong reaction.
Chapter 12
Enzyme Inhibition
Key Concepts 12.2
Enzyme inhibitors interact reversibly or irreversibly with an
enzyme to alter its KM and/or Vmax values.
A competitive inhibitor binds to the enzymes active site
and increases the apparent KM for the reaction.
An uncompetitive enzyme inhibitor affects catalytic activity
such that both the apparent KM and the apparent Vmax
decrease.
A mixed enzyme inhibitor alters both catalytic activity and
substrate binding such that the apparent Vmax decreases and
the apparent KM may increase or decrease.
Inhibitors
1.
2.
3.
38
Page 378
Oseltamivir (Tamiflu)
Oseltamivir (Tamiflu)
PDBid 2HU4
Adenosine Deaminase:
Transition State Analog Inhibitor
Competitive Inhibitors
1. Competitive inhibitor: A
substance that
competes directly with a
normal substrate for an
enzyme-binding site
2. Inhibitor resembles the
substrate to the extent
that it specifically binds
to the active site but
differs from it so as to
be unreactive
42
Competitive Inhibitors
43
Page 377
Competitive Inhibitors
3. I, the inhibitor, binds reversibly to the enzyme and
is in rapid equilibrium with it so that KI+ and EI
enzyme-inhibitor complexis catalytically inactive.
4. Acts by reducing the concentration of free enzyme
available for substrate binding.
44
Page 378
Competitive Inhibitors
5. The inhibitor does not affect the turnover number of the enzyme
45
Figure 12-6
46
Page 380
Uncompetitive Inhibition
1.
2.
3.
51
Page 381
Uncompetitive Inhibition
4.
53
55
Page 382
Mixed (Noncompetitive)
Enzyme Inhibition
Mixed (Noncompetitive)
Enzyme Inhibition
Mixed Inhibition
4. Mixed inhibitors are therefore effective at both high and low substrate
concentrations
1.
Applied Enzyme
Inhibition
2.
3.
Acquired immunodeficiency
syndrome (AIDS) is caused by
human immunodeficiency virus
type 1
HIV -1 is targeted to and
specifically replicates within
helper T cells, essential
components of the immune
system
Reverse transcriptase inhibitors
are only partially effective
a. 3-azido-3-deoxythymidine
(AZT) was the first drug to be
approved by the FDA to fight
AIDS, but only slowed the
progression of an HIV
infection
b. Under the selective pressure
of an anti-HIV drug such as
AZT, the drugs target
receptor rapidly evolves to a
60
drug-resistant form
Enzyme Inhibition
4. HIV-1 polyproteins are cleaved by HIV-1 protease
5. Aspartic proteases and their catalytic mechanism
a. Proteolytic enzymes have three essential
catalytic components
i.
A nucleophile to attack the carbonyl C
atom of the scissile peptide to form a
tetrahedral intermediate
ii. An electrophile to stabilize the negative
charge that develops on the carbonyl O
atom of the tetrahedral intermediate
iii. A proton donor so as to make the amide N
atom of the scissile peptide a good leaving
group
61
Enzyme
Inhibition
6. HIV-1 protease
inhibitors are effective
anti-AIDS agents
a. HIV-1 protease
differs from
eukaryotic aspartic
proteases in that it
is a homodimer of
99-residue
subunits, even
though its x-ray
structure
resembles those of
eukaryotic aspartic
proteases
62
Chapter 12
Enzyme Inhibition
Checkpoint 12.2
What distinguishes an inhibitor from an inactivator?
Why might an enzymes substrate, transition state, and
product all serve as starting points for the design of a
competitive inhibitor?
Describe the effects of competitive, uncompetitive, and
mixed inhibitors on KM and Vmax.
How can inhibitor binding to an enzyme be quantified?
How does pure noncompetitive inhibition differ from other
forms of inhibition?
Chapter 12
Control of Enzyme Activity
Key Concepts 12.3
Allosteric effectors bind to multisubunit enzymes such as
aspartate transcarbamoylase, thereby inducing cooperative
conformational changes that alter the enzymes catalytic
activity.
Phosphorylation and dephosphorylation of an enzyme such
as glycogen phosphorylase can control its activity by shifting
the equilibrium between more active and less active
conformations.
Regulation of
Enzymatic
Activity
1.
67
69
Regulation of
Enzymatic
Activity
Figure 12-12
Regulation of
Enzymatic
Activity
Page 388
71
Conformational Changes:
Glycogen Phosphorylase
Glycogen phosphorylase
PDBids 8GPB and 7GPB
Glycogen Phosphorylase:
Control by Phosphorylation
Protein Phosphorylation
2. When there is high demand for ATP (low [ATP], low [G6P], and
high [AMP]), glycogen phosphorylase is stimulated and glycogen
synthase is inhibited, so flux favors glycogen breakdown
79
Figure 12-14b
Protein Phosphorylation
3. When [ATP] and [G6P] are high, the reverse is true
and glycogen synthesis is favored
4. AMP promotes phosphorylases T(inactive)R(active)
conformational shift by binding to the R state of the
enzyme at its allosteric effector site
80
Figure 12-15
Chapter 12
Control of Enzyme Activity
Checkpoint 12.3